IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD

Abstract

Background/Aims: IL-1β is an important mediator of “inflammation-cancer" transformation through IL-1β/NF-κB/COX-2/HIF-1α signaling pathway, whereas certain portion of patients with lung adenocarcinoma (LUAD) still suffer from rapid tumor progression in clinical practice, indicating the occurrence of potential bypass. Methods: Real-time polymerase chain reaction was applied to examine the expressions of mir-144-3p, WT1, NF-κB, COX2 and HIF-1α at the mRNA level in 127 LUAD samples and corresponding adjacent tissues. miR-144-3p mimic and antagormiR were used to trigger activation and suppression of miR-144-3p in A549 cells, respectively. MTT assay and Western blotting analysis were carried out to evaluate the cell proliferation. Stable clones with over-expression or knockdown of WT1 were generated with plasmid or shRNA by lentiviral vector technology in H1568 and H1650 NSCLC cell lines, respectively. Dual luciferase reporter assay was performed to validate the effect of miR-144-3p on WT1D. Xenograft model was established for in vivo experiment, and TCGA data were extracted for validation. Results: miR-144-3p could suppress the WT1D expression at the post-transcriptional level, hence regulating cell proliferation in LUAD. WT1 and COX-2 were independent prognostic factors of LUAD patients. In addition, inhibition of IL-1β/miR-144-3p/WT1D and IL-1β/NF-κB/COX-2/HIF-1α pathways using miR-144-3p mimic and Celecoxib, respectively, displayed synergistic suppressive effect on cell proliferation in LUAD. Conclusion: A de novo IL-1β/miR-144-3p/WT1D axis was involved in proliferative regulation of LUAD. Moreover, simultaneous blockade of both IL-1β/miR-144-3p/WT1D and IL-1β/NF-κB/COX-2/ HIF-1α pathways might have synergistic suppressive effect on cell proliferation in LUAD.

Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer

“…Multiple experiments in vitro and vivo have shown that IL-1β has a tumor-promoting effect and can promote lung cancer metastasis through adhesion, invasion, and tumor angiogenesis of lung cancer cells. 24 …”

The expression, significance and function of cancer susceptibility candidate�9 in lung squamous cell carcinoma: A bioinformatics and in�vitro investigation

“…In terms of histology, there are two types of LC: Non-small cell LC (NSCLC) and small cell LC, of which the former makes up 85% of all cases (4). NSCLC is comprised of two subtypes: Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) (3,5). Drugs targeting mutated versions of the epidermal growth factor receptor (EGFR), GTPase KRas and ALK tyrosine kinase receptor proteins mutations have already demonstrated beneficial effects in patients with LUAD (6).…”

Activation of NF‐κB signaling pathway during HCG‐induced VEGF expression in luteal cells

“…Furthermore, NF‐κB is closed with the inflammatory response through interleukin (IL)‐1β production (Wu et al, ; Yang et al, ), including ovarian grannulosa cells (Yang et al, ). Some reports demonstrated NF‐κB was expressed in human granulosa luteal cells and activated by TNF‐α, resulting in degradation of IκBalpha and mobilization of NF‐κB into the nucleus (Gonzalez‐Navarrete et al, ), and NF‐κB was also involved in the regulation of rat luteal function as a survival factor and inhibitor of 20alpha‐hydroxysteroid dehydrogenase (Telleria et al, ).…”